1Sacco RL,Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for heahhcare professionals from A merican Heart Association/American Stroke Association Council on stroke:co-sponsored by the Council of Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke, 2006, 37:577-617.
2Schrader J, Luders S, Kulschewski A, et al. Morbidity and mortality after stroke. Eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke, 2005, 36:1218-1226.
3Wilcox R,Bousser MG, Betteridge D J, et al. Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke ; results from PROactive( PROspective pioglitAzone Clinical Trial In macroVascular Event s 04). Stroke, 2007,38 : 865-873.
4Amarenco P, Bogousslavsky J, Callahan A, et al. High dose atorvastatin after stroke or transient ischemic attack. N Engl J Med, 2006,355 : 549-559.
5SPORTIF Executive Steering Committee for the SPORTIF V investigators. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA? 2005,293:690-698.
6Akins P, Feldman HA, Zoble R, et al. Secondary stroke prevention with Ximelagatran versus warfarin in patients with atrial fibrillation:pooled analysis of SPORTIF Ⅲ and Ⅴ clinical trials. Stroke, 2007,38 : 874-880.
7The ESPIRIT Study Group. Medium intensity oral anticoagulant versus aspirin after cerebral ischeamia of arterial origin (ESPIRIT): a randomised controlled trial. Lancet Neurol, 2007,6 : 115-124.
8The ESPIRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischemia of arterial origin (ESPIRIT) : randomised controlled trial. Lancet, 2006, 367: 1665-1673.
9Bhatt DL,Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Eng J Med ,2006,354 : 1706-1717.
10Howad G, McClure LA, Krakauer JW, et al. Stroke and the statistics of the aspirin/clopidogrel secondary prevention trials. Curr Opin Neurol, 2007,20 : 71-77.
